RxDoctor Payments Data

Eric Denny

Psychiatric/Mental Health · Morris, ILNPI 1316436082

Payments from drug & device makers

$3,870in general payments, 2019–2025

Across 279 payments — averaging $13.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Supernus Pharmaceuticals, Inc.$408
  • Johnson & Johnson$404
  • Otsuka America Pharmaceutical, Inc.$272
  • Axsome Therapeutics, Inc.$270
  • Takeda Pharmaceuticals U.S.A., Inc.$239
  • plus $772 from 13 others

What the payments were for

  • Food & beverage$3,78598%
  • Education$852%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,870 in reported general payments places this provider in the 90th percentile of 922 psychiatric/mental health providers in Illinois.

See all psychiatric/mental health providers in Illinois

Medicare billing

Part B allowed, 2024
$47,714
Medicare patients
68
Services billed
665

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate14$109,291
VraylarCariprazine Hcl30$46,984
TrintellixVortioxetine Hydrobromide24$22,704
Lurasidone Hcl15$6,680
Aripiprazole49$4,742
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine82$2,723
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine30$2,451
Alprazolam229$2,004
Bupropion XlBupropion Hcl88$1,714
Lamotrigine97$1,660
Quetiapine Fumarate106$1,551
Trazodone Hcl120$1,525
Clonazepam185$1,494
Duloxetine Hcl85$1,461
Venlafaxine Hcl ErVenlafaxine Hcl65$1,390

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$35$109,29114 claims
AbbVieVraylar$1,506$46,98430 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$239$22,70424 claims
Almatica Pharma LLCSertraline Hcl$81$58092 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 922 psychiatric/mental health providers in Illinois.

Other psychiatric/mental health in Morris

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →